We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Improving End-of-Life Care for Dementia Patients

By HospiMedica staff writers
Posted on 12 Nov 2004
A new study calls for creative and wide-reaching solutions to the problem of sub-optimal end-of-life care for patients with dementia.

An estimated 500,000 people die every year in the United States alone suffering from Alzheimer's or related diseases, and many of them receive inadequate pain control, are subjected to ineffective and invasive therapies such as tube feedings, and do not receive the benefits of hospice care. More...


Among the barriers to better care is the unwillingness of doctors and families to think of dementia as a terminal illness, since dementia patients decline very slowly. A second barrier is the inability of doctors to predict the time of death. U.S. insurance plans offer hospice benefits only to patients with a life expectancy of six months or less, but the median survival of dementia patients is several years and varies greatly. Patient assessment is difficult because patients can no longer describe symptoms or discomfort. A third barrier is the poor fit between dementia and healthcare financial incentives, which reward providers for transferring rapidly declining patients into hospitals, where the process of dying is prolonged. "The only parties who may not be better off from the transfer,” note the authors, "are the patient and family.”

The solutions involve education, better prognostic tools, and changes in the healthcare system. Perhaps the most urgent is the need to align financial incentives with the provision of palliative care. The authors suggest relaxing the criteria for hospice to accommodate earlier referral of patients with dementia. Caregivers need to shift away from curative to palliative care. The study, one of four on the subject, was conducted by three geriatricians at the University of Chicago (IL, USA) and was published in the October 2004 issue of the Journal of General Internal Medicine.

"The nature of illness is the root cause of the problem,” explained first author Greg Sachs, M.D., professor of medicine at the University of Chicago. "Our healthcare system is oriented toward treatment of acute illness but dementia produces a long, slow, unpredictable decline.”

"The pace of death has slowed so suddenly that we seem to have lost our ability to recognize it,” noted Christopher Callahan, M.D., of the Indiana University Center for Aging Research (Bloomington, IN, USA) in an editorial that tied the four studies together.


Related Links:
University of Chicago >

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.